Laprophan, a Mediterrania Capital Partners portfolio company, acquires Rivopharm to accelerate its international expansion

by Mediterrania Capital Partners

The acquisition represents a transformational milestone in Laprophan's development and marks the Group's first acquisition in Europe. The transaction significantly strengthens Laprophan's European foo...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

Kenta Capital and Avalis Launch a Debt F...

by Kenta Capital

This pioneering initiative is designed to support both organic and ino...

Photos Stream